businesspress24.com - CSE: 2017-1003 - New Listing - Ortho Regenerative Technologies Inc. (ORTH)
 

CSE: 2017-1003 - New Listing - Ortho Regenerative Technologies Inc. (ORTH)

ID: 1523368

(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 10/05/17 -- The common shares of Ortho Regenerative Technologies Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at

Ortho RTi is an emerging Orthopaedic and Sports Medicine technology company dedicated to the development of novel therapeutic tissue repair devices to dramatically improve the success rate of sports medicine surgeries. We are committed to improving patients'' lives through increasing the success rates of surgeries for soft tissue injuries. Our proprietary biopolymer has been specifically designed to increase the healing rates of sports related injuries to ligaments, tendons and cartilage. The polymer can be directly placed into the site of injury by a surgeon during a routine operative procedure without significantly extending the time of the surgery and without further intervention.

L''inscription a la cote de CSE des actions ordinaires de Ortho Regenerative Technologies Inc. a ete approuvee.

Les documents d''inscription et de divulgation seront disponibles sur

Ortho RTi est une societe emergente de technologie de medecine orthopedique et de sport dediee au developpement de nouveaux dispositifs de reparation de tissus therapeutiques pour ameliorer considerablement le taux de reussite des cabinets de medecine sportive. Nous nous sommes engages a ameliorer la vie des patients en augmentant les taux de reussite des chirurgies pour les lesions des tissus mous. Notre biopolymere brevete a ete specifiquement concu pour augmenter les taux de guerison des blessures liees aux sports dans les ligaments, les tendons et le cartilage. Le polymere peut etre directement place dans le site d''une blessure par un chirurgien lors d''une procedure chirurgicale de routine sans prolonger significativement le temps de la chirurgie et sans intervention supplementaire.





Contacts:
Canadian Securities Exchange (CSE)




Listings
(416) 367-7340

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  CSE: 2017-1004 - Name and Symbol Change - 360 Capital Financial Services Group Inc. (TSZ)
Grey Cloak''s Acquisition Target Eqova Exhibits at Denver''s Integrative Medicine Summit
Bereitgestellt von Benutzer: Marketwired
Datum: 05.10.2017 - 12:50 Uhr
Sprache: Deutsch
News-ID 1523368
Anzahl Zeichen: 3448

contact information:
Contact person:
Town:

TORONTO, ONTARIO


Phone:

Kategorie:

Investment Services & Trading


Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 436 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"CSE: 2017-1003 - New Listing - Ortho Regenerative Technologies Inc. (ORTH)
"
steht unter der journalistisch-redaktionellen Verantwortung von

Canadian Securities Exchange (CSE) (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Canadian Securities Exchange (CSE)



 

Who is online

All members: 10 563
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 87


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.